163 related articles for article (PubMed ID: 23961670)
1. [Adalimumab].
Kasama T
Nihon Rinsho; 2013 Jul; 71(7):1218-24. PubMed ID: 23961670
[TBL] [Abstract][Full Text] [Related]
2. [Prospective study of the efficiency and safety of adalimumab in treatment of active established rheumatoid arthritis].
Pomirleanu C; Ancuţa C; Macovei L; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):395-400. PubMed ID: 23077926
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
Segal B; Rhodus NL; Patel K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):778-87. PubMed ID: 18930662
[TBL] [Abstract][Full Text] [Related]
4. [Fully human anti TNF-alpha monoclonal antibodies (adalimumab, golimumab)].
Hirohata S
Nihon Rinsho; 2007 Jul; 65(7):1202-8. PubMed ID: 17642233
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab in the treatment of rheumatoid arthritis.
Voulgari PV; Kaltsonoudis E; Papagoras C; Drosos AA
Expert Opin Biol Ther; 2012 Dec; 12(12):1679-86. PubMed ID: 22954150
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
[TBL] [Abstract][Full Text] [Related]
7. Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis.
Andrisani G; Gremese E; Guidi L; Papa A; Marzo M; Felice C; Pugliese D; Armuzzi A
Reumatismo; 2013 May; 65(2):75-8. PubMed ID: 23877411
[TBL] [Abstract][Full Text] [Related]
8. [Paradigm shift in the treatment of rheumatoid arthritis by biologics].
Tanaka Y
Rinsho Byori; 2008 Apr; 56(4):309-15. PubMed ID: 18516965
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
[TBL] [Abstract][Full Text] [Related]
10. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
Woodrick RS; Ruderman EM
Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
[TBL] [Abstract][Full Text] [Related]
11. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up.
Dewedar AM; Shalaby MA; Al-Homaid S; Mahfouz AM; Shams OA; Fathy A
Int J Rheum Dis; 2012 Jun; 15(3):330-5. PubMed ID: 22709496
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab therapy in patients with active rheumatoid arthritis.
Ancuţa C; Ancuţa E; Miu S; Iordache C; Belibou C; Chirieac R
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):710-5. PubMed ID: 20191820
[TBL] [Abstract][Full Text] [Related]
13. Crohn's disease diagnosis during adalimumab treatment.
Fernández Salazar L; Barrio Andrés J; González Hernández JM
Scand J Gastroenterol; 2013 Feb; 48(2):254-5. PubMed ID: 23061423
[TBL] [Abstract][Full Text] [Related]
14. New biologics for rheumatoid arthritis.
Choy E
J R Coll Physicians Edinb; 2011 Sep; 41(3):234-7. PubMed ID: 21949922
[TBL] [Abstract][Full Text] [Related]
15. [Targeting CD20 in rheumatoid arthritis].
Saito K; Tanaka Y
Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
[TBL] [Abstract][Full Text] [Related]
16. [The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results].
Karateev DE; Nasonov EL; Luchikhina EL; Mazurov VI; Salikhov IG; Shmidt EI; Shostak NA
Ter Arkh; 2012; 84(8):22-8. PubMed ID: 22994084
[TBL] [Abstract][Full Text] [Related]
17. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].
Yamaguchi Y; Yamamoto K
Clin Calcium; 2007 Apr; 17(4):463-73. PubMed ID: 17404474
[TBL] [Abstract][Full Text] [Related]
18. [Adalimumab (Humira)--efficacy in rheumatoid arthritis treatment with particular reference to working ability].
Grazio S
Reumatizam; 2008; 55(2):62-7. PubMed ID: 19024278
[TBL] [Abstract][Full Text] [Related]
19. [Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review].
Scailteux LM; Guedes C; Polard E; Perdriger A
Presse Med; 2015 Jan; 44(1):4-10. PubMed ID: 25534463
[TBL] [Abstract][Full Text] [Related]
20. A new era in rheumatoid arthritis treatment.
Costello JC; Halverson PB
WMJ; 2003; 102(7):29-33. PubMed ID: 14711021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]